Abstract:Abstract Research into lipoprotein metabolism has developed because understanding lipoprotein metabolism has important clinical indications. Lipoproteins are risk factors for cardiovascular disease. Recent advances include the identification of factors in the synthesis and secretion of triglyceride rich lipoproteins, chylomicrons (CM) and very low density lipoproteins (VLDL). These included the identification of microsomal transfer protein, the cotranslational targeting of apoproteinB (apoB) for degradation regulated by the availability of lipids, and the characterization of transport vesicles transporting primordial apoB containing particles to the Golgi. The lipase maturation factor 1, glycosylphosphatidylinositol-anchored high density lipoprotein binding protein 1 and an angiopoietin-like protein play a role in lipoprotein lipase (LPL)-mediated hydrolysis of secreted CMs and VLDL so that the right amount of fatty acid is delivered to the right tissue at the right time. Expression of the low density lipoprotein (LDL) receptor is regulated at both transcriptional and post-transcriptional level. Proprotein convertase subtilisin/kexin type 9 (PCSK9) has a pivotal role in the degradation of LDL receptor. Plasma remnant lipoproteins bind to specific receptors in the liver, the LDL receptor, VLDL receptor and LDL receptor-like proteins prior to removal from the plasma. Reverse cholesterol transport occurs when lipid free apoAI recruits cholesterol and phospholipid to assemble high density lipoprotein (HDL) particles. The discovery of ABC transporters (ABCA1 and ABCG1) and scavenger receptor class B type I (SR-BI) provided further information on the biogenesis of HDL. In humans HDL-cholesterol can be returned to the liver either by direct uptake by SR-BI or through cholesteryl ester transfer protein exchange of cholesteryl ester for triglycerides in apoB lipoproteins, followed by hepatic uptake of apoB containing particles. Cholesterol content in cells is regulated by several transcription factors, including the liver X receptor and sterol regulatory element binding protein. This review summarizes recent advances in knowledge of the molecular mechanisms regulating lipoprotein metabolism.

Post-translational regulation of the low-density lipoprotein receptor provides new targets for cholesterol regulation

Recent developments in the regulation of cholesterol transport by natural molecules

Recent advances in physiological lipoprotein metabolism

Regulation of hepatic cholesterol metabolism in man

Receptor-mediated low-density lipoprotein catabolism

Studies on Very Low Density Lipoprotein Receptor in Animal

Research on Expression and Regulation of the Low Density Lipoprotein Receptor(LDLR)Gene

New Insights in Regulation Factors of Lipoprotein Lipase

Lowering Low-Density Lipoprotein Cholesterol: from Mechanisms to Therapies

microRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator.

Receptors and Lipid Transfer Proteins in HDL Metabolism

Feeding-Induced Regulation of Cholesterol Metabolism: A Unified Proposal

Dysregulation of the Low-Density Lipoprotein Receptor Pathway is Involved in Lipid Disorder-Mediated Organ Injury.

Cholesterol homeostasis and cancer: a new perspective on the low-density lipoprotein receptor

Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins

New Insights Into the Regulation of HDL Metabolism and Reverse Cholesterol Transport

Hepatic deficiency of low density lipoprotein receptor-related protein-1 reduces high density lipoprotein secretion and plasma levels in mice

IDOL stimulates clathrin-independent endocytosis and multivesicular body-mediated lysosomal degradation of the low-density lipoprotein receptor.

Lipoprotein Lipase and Its Regulators: an Unfolding Story.

Native LDL Upregulation of ATP-Binding Cassette Transporter-1 in Human Vascular Endothelial Cells

Dual Effects of Oxidized Low-Density Lipoprotein on LXR-ABCA1-apoA-I Pathway in 3T3-L1 Cells.